Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 08:37:49 +0200Fri, 05 Jul 2024 16:25:00 +0200Opinion/decision on a Paediatric investigation plan (PIP): Regkirona, Regdanvimab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Vaccines, PIP number: P/0238/2023https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-002961-pip01-21-m02Opinion/decision on a Paediatric investigation plan (PIP): Regkirona, Regdanvimab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Vaccines, PIP number: P/0238/2023https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-002961-pip01-21-m02Fri, 05 Jul 2024 16:25:00 +0200Human medicine